358 related articles for article (PubMed ID: 30826057)
1. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
[TBL] [Abstract][Full Text] [Related]
2. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
[TBL] [Abstract][Full Text] [Related]
3. Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury.
Lee S; Piao C; Kim G; Kim JY; Choi E; Lee M
Eur J Pharm Sci; 2018 Mar; 114():275-284. PubMed ID: 29292016
[TBL] [Abstract][Full Text] [Related]
4. Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.
Li K; Yang J; Han X
Int Immunopharmacol; 2016 May; 34():114-128. PubMed ID: 26945830
[TBL] [Abstract][Full Text] [Related]
5. High-mobility group box 1 mediates persistent splenocyte priming in sepsis survivors: evidence from a murine model.
Valdés-Ferrer SI; Rosas-Ballina M; Olofsson PS; Lu B; Dancho ME; Li J; Yang H; Pavlov VA; Chavan SS; Tracey KJ
Shock; 2013 Dec; 40(6):492-5. PubMed ID: 24089009
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
Susa Y; Masuda Y; Imaizumi H; Namiki A
Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
[TBL] [Abstract][Full Text] [Related]
7. Oxymatrine attenuates sepsis-induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF-κB signaling pathway.
He J; Qin W; Jiang S; Lin Y; Lin Y; Yang R; Xu M; Liu Q
Drug Dev Res; 2024 Jun; 85(4):e22219. PubMed ID: 38845211
[TBL] [Abstract][Full Text] [Related]
8. Icariin and icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation model in C57BL/6 J mice.
Liu L; Zhao Z; Lu L; Liu J; Sun J; Wu X; Dong J
Int Immunopharmacol; 2019 Mar; 68():95-105. PubMed ID: 30616172
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.
Inada M; Shindo M; Kobayashi K; Sato A; Yamamoto Y; Akasaki Y; Ichimura K; Tanuma SI
PLoS One; 2019; 14(5):e0216358. PubMed ID: 31100066
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth.
Inada M; Sato A; Shindo M; Yamamoto Y; Akasaki Y; Ichimura K; Tanuma SI
Anticancer Res; 2019 Dec; 39(12):6743-6750. PubMed ID: 31810939
[TBL] [Abstract][Full Text] [Related]
12. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
13. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
[No Abstract] [Full Text] [Related]
14. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury.
Fan H; Tang HB; Chen Z; Wang HQ; Zhang L; Jiang Y; Li T; Yang CF; Wang XY; Li X; Wu SX; Zhang GL
J Neuroinflammation; 2020 Oct; 17(1):295. PubMed ID: 33036632
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive activity of the novel RAGE inhibitor, papaverine, in a mouse model of chronic inflammatory pain.
Yoshizawa K; Takeuchi K; Nakamura T; Ukai S; Takahashi Y; Sato A; Takasawa R; Tanuma SI
Synapse; 2021 Mar; 75(3):e22188. PubMed ID: 32979223
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
17. Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses.
Bi X; Yan X; Jiang B; Liang J; Zhou J; Lu S; Liu J; Luo L; Yin Z
Toxicol Appl Pharmacol; 2021 Dec; 433():115778. PubMed ID: 34755645
[TBL] [Abstract][Full Text] [Related]
18. Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages.
Ogawa N; Nakajima S; Tamada K; Yokoue N; Tachibana H; Okazawa M; Oyama T; Abe H; Yamazaki H; Yoshimori A; Sato A; Kamiya T; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
Arch Biochem Biophys; 2021 Oct; 711():109029. PubMed ID: 34517011
[TBL] [Abstract][Full Text] [Related]
19. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
Lee W; Ku SK; Bae JW; Bae JS
Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
